KARBE FRANK 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
KARBE FRANK
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+10,000→ 10,000 totalExercise: $7.40Exp: 2032-05-24→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to one-third of the shares of common stock on April 25, 2023, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.